This guide is educational information, not personal medical advice. The source-check date records editorial work, not a clinician review. Read our medical disclaimer.

Why treatment may change

A regimen may be reconsidered because of side effects, interactions, difficulty following the schedule or a viral load that is not adequately controlled. Some people discuss a change while suppressed because a different regimen may better fit their circumstances.

A proposed change has a specific goal. Ask what it is expected to improve and what tradeoffs may come with it. A different pill count or injection schedule is only one part of the decision.

Sources for this section: [1][2]

Review the full history

Your clinician considers prior HIV treatments, earlier and current resistance results, viral response, other health conditions and all medicines and supplements. Bring old reports or pharmacy information if you have them; mention previous PrEP or PEP.

If you have hepatitis B, some HIV medicines also act against it. Interrupting hepatitis B-active treatment can have liver consequences, so coordination and an individualized plan are especially important.

Sources for this section: [2][3]

Compare the options

Ask about food and timing requirements, possible interactions, side effects, pill burden or injection visits, and how easily you can obtain the medicine. Explain changing work, transport or privacy needs; a clinically suitable plan must also be usable.

Check a new regimen against every other prescription and nonprescription product. If another clinician prescribes a medicine, ensure both teams know the complete plan and who will review interactions.

Sources for this section: [2][1]

Make the transition explicit

Before changing, confirm that the new prescription is available and obtain written instructions explaining the transition. Ask whom to call if the pharmacy cannot fill it or if the instructions differ from what was discussed.

Do not independently stop, overlap or substitute medicines. If a side effect is urgent, contact the care team promptly for advice specific to the situation rather than waiting for a scheduled visit.

Sources for this section: [1][3]

Check the new regimen

NIH recommends viral load testing after a regimen change to check response. Ask when the sample is due, how results will reach you and which symptoms should prompt a call. Keep a record of the new medicine names and start date.

A change is not a failure. If the new routine, side effects or access arrangements are difficult, report the specific problem so the team can reassess. Keep follow-up appointments even if you feel well.

Sources for this section: [4][1]

Prevent a gap during the change

A new prescription may require the pharmacy to order stock or obtain an authorization. Ask when the medicine will be ready and whether the clinic should be contacted if there is a delay. Confirm the transition instructions with the prescriber and pharmacist, especially when one treatment is administered at a clinic and another is dispensed by a pharmacy.

Keep the old and new names and the agreed follow-up date in your records. If what you receive is different from the written plan, call for clarification. A change should solve a defined problem while maintaining HIV control and, where relevant, coordinated hepatitis B treatment.

Sources for this section: [2][3]

What happens after a switch?

Follow-up checks whether the new treatment is tolerable, practical and maintaining viral suppression. NIH recommends close monitoring during the first three months after a switch, with the exact tests and timing tailored to the reason for the change and the person’s health.

Ask which symptoms or difficulties should be reported before the planned appointment, when the viral load will be checked and who will discuss the result. If the new plan is hard to obtain or follow, explain the problem early so the team can reassess it.

Sources for this section: [4][2][5]

Check the source

Sources & editorial note

We use the sources below to support this guide. Follow a source link for its full guidance and any later changes. Source checking does not replace medical review or a conversation with your care team.

  1. Adverse Effects of Antiretroviral Medications NIH ClinicalInfo. Accessed .
  2. Treatment Goals NIH ClinicalInfo. Accessed .
  3. Hepatitis B Virus/HIV Coinfection NIH ClinicalInfo. Accessed .
  4. Plasma HIV-1 RNA and CD4 Count Monitoring NIH ClinicalInfo. Accessed .
  5. Optimizing Antiretroviral Therapy in the Setting of Viral Suppression NIH ClinicalInfo. Accessed .

Prepared by HIV Guide editorial team. How we write and check our guides · Contact and corrections information